Uncovering bacterial co-infections in COVID-19 patients with broader diagnostics

April 10, 2020

Healthcare facilities need to provide the best possible care and outcomes for patients with COVID-19. To do this and truly protect patients not just from the risks associated with the initial COVID-19 infection but also with bacterial co-infections acquired within the healthcare system, hospitals should consider simultaneously incorporating broader testing for bacterial co-infections that can be acquired during a patient’s hospital stay. The solutions are readily available, FDA-cleared and easily integrated in the form of PCR, for lower respiratory specimens, LRT aspirate and BAL panels, and diagnostic technologies that quickly analyze pathogens and identify bacterial co-infections.

About the author: Oliver Schacht is the CEO of OpGen.

Back to HCB News

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.



You Must Be Logged In To Post A Comment Se connecter Se você já criou uma conta, use seu endereço de e-mail e senha para entrar usando o formulário abaixo. Problèmes de connexion: Click here si vous rencontrez des problèmes de connexion. Adresse e-mail: Mot de passe: Mot de passe oublié ? Problèmes de connexion ? Voir notre « Mentions légales » et Notice de Confidentialité Registre L'inscription est gratuite et facile. Aproveite os benefícios dos principais produtos novos e inovadores do mundo. Mercado de equipamentos médicos usados. Inscrivez-vous maintenant !